Diseases [C] » Nutritional and Metabolic Diseases [C18] » Nutrition Disorders » Malnutrition » Deficiency Diseases » Avitaminosis » Vitamin D Deficiency
Description
A nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. (From Cecil Textbook of Medicine, 19th ed, p1406) MeSH
Hierarchy View
Subtype Terms (1)
Rickets
6 drugs (4 approved, 2 experimental)
Approved Indicated Drugs (2)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (5)
Other Experimental Indicated Drugs (24)
Organization Involved with Phase 4 Indications (102)
Albany College of Pharmacy and Health Sciences
Almazov National Medical Research Centre
Canadian Institutes of Health Research (CIHR)
Children's Memorial Health Institute, Poland
Cooperativa Asistencia Sindicato Médico Uruguay
Crohn's and Colitis Foundation
Fundacio Salut i Envelliment UAB
Grassroots Health Nutrition Institute
Hortense & Louis Rubin Dialysis Center
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Instituto Nacional de la Nutrición Salvador Zubiran
King Edward Medical University
King Faisal Specialist Hospital
Kwang Dong Pharmaceutical co., ltd.
Nanyang Technological University
National Institute for Health Research, United Kingdom
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Aging (NIA)
National Institutes of Health (NIH)
New York Presbyterian Hospital
Postgraduate Institute of Medical Education and Research
Shahid Beheshti University of Medical Sciences
Tameside Hospital NHS Foundation Trust
The Children's Memorial Health Institute
Organization Involved with Phase 3 Indications (59)
All India Institute of Medical Sciences
Canadian Critical Care Trials Group
Indian Council of Medical Research
Moorgreen Hospital, Southampton
Organization Involved with Phase 2 Indications (43)
Case Western Reserve University
Children's University Hospital, Ireland
City of Hope National Medical Center
Foundation of Orthopedic Trauma
Imam Abdulrahman Bin Faisal University
International Heart Institute of Montana
Menzies Institute for Medical Research
Organization Involved with Phase 1 Indications (25)
IDeA States Pediatric Clinical Trials Network
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Organization Involved with Other Experimental Indications (130)
Albert Einstein Israelite Hospital
Applied Science Private University, Amman -Jordan
Bangabandhu Sheikh Mujib Medical University
British Columbia Cancer Agency
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Diabetes Action Research and Education Foundation
Federal University of Health Science of Porto Alegre
Higher School of Applied Sciences (VIST)
Hospital del Trabajador de Santiago
Icahn School of Medicine at Mount Sinai
Irish Government Department of Agriculture, Food and Fisheries, Ireland
Liverpool John Moores University
Methodist Cancer Center, Houston, Texas
National Center for Maternal and Child Health Research, Mongolia
National Center for Research Resources (NCRR)
People's Liberation Army of China
Pontificia Universidad Catolica de Chile
Princess Anna Mazowiecka Hospital
Queen Sirikit National Institute of Child Health
Rashid Centre for Diabetes and Research
Royal National Orthopaedic Hospital NHS Trust
Shin Kong Wu Ho-Su Memorial Hospital
Sitaram Bhartia Institute of Science and Research
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
The Physicians' Services Incorporated Foundation
Top Institute Food and Nutrition
TriService Nursing Research Program
United States Department of Agriculture
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.